Acelrx Pharmaceuticals Inc. buy tamam
Start price
24.04.19
/
50%
€65.49
Target price
04.11.21
€117.26
Performance (%)
-77.63%
End price
05.11.21
€14.65
Summary
This prediction ended on 05.11.21 with a price of €14.65. Massive losses of -77.63% were the result for the BUY prediction by tamam. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Acelrx Pharmaceuticals Inc. | -7.210% | -7.210% | 41.853% | -95.511% |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by tamam for this prediction
In the thread Acelrx Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von stratec zu
tamam stimmt am 23.10.2018 der Buy-Einschätzung von stratec mit dem Kursziel 7,3$ zu.
Überschrift: ACRX PDUFA action date November 3, 2018, for sufentanil for the management of moderate-to-severe pain
In the thread Trading Acelrx Pharmaceuticals Inc.
Die von tamam gewählte maximale Laufzeit wurde überschritten
Stopped prediction by tamam for Acelrx Pharmaceuticals Inc.
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€70.72
23.10.18
23.10.18
€131.69
23.04.19
23.04.19
-13.27%
23.04.19
23.04.19
